This must-attend one-day conference will be the ideal place to hear the very latest thinking from senior experts and leading speakers from the MHRA, the European Medicines Agency (EMA), the life science industry, the NHS, NICE, academia, patient organisations and investment firms.

The conference programme addresses some hot topics and developments to support innovation and optimise pathways and timely access to new medicines including:

• Accelerated access review in the UK
• UK Early Access to Medicines Scheme: two years on
• EU early access tools
• Adaptive pathways
• The new EMA’s PRIME (Priority Medicines) scheme
• What are the benefits of accelerated assessment in the EU?

Professor Sir John Bell, Chair, Accelerated Access Review’s Expert Advisory Group and Sir Hugh Taylor, Independent Chair, Accelerated Access Review will provide keynote presentations and an impressive line-up of expert speakers will discuss and debate these timely and important topics.

Almost 80 organisations attended the 2015 event from countries across the world. Come be a part of this exciting event and drive your business further.

MediWales members receive 10% discount on attendance rate through United Life Sciences partnership. See more here.